Sustainable Growth Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $357K | Sell |
881
-631,159
| -100% | -$256M | ﹤0.01% | 53 |
|
|
2025
Q1 | $315M | Sell |
632,040
-80,166
| -11% | -$39.9M | 1.75% | 22 |
|
|
2024
Q4 | $371M | Sell |
712,206
-95,286
| -12% | -$49.6M | 1.86% | 24 |
|
|
2024
Q3 | $499M | Buy |
807,492
+110,569
| +16% | +$68.4M | 2.12% | 23 |
|
|
2024
Q2 | $385M | Sell |
696,923
-70,513
| -9% | -$39M | 1.7% | 26 |
|
|
2024
Q1 | $446M | Sell |
767,436
-16,383
| -2% | -$9.52M | 1.87% | 22 |
|
|
2023
Q4 | $416M | Sell |
783,819
-28,079
| -3% | -$14.9M | 1.89% | 22 |
|
|
2023
Q3 | $411M | Sell |
811,898
-2,021
| -0.2% | -$1.02M | 2.09% | 20 |
|
|
2023
Q2 | $425M | Buy |
813,919
+97,652
| +14% | +$50.9M | 2.01% | 20 |
|
|
2023
Q1 | $413M | Buy |
716,267
+4,252
| +0.6% | +$2.45M | 2.39% | 19 |
|
|
2022
Q4 | $392M | Buy |
712,015
+80,295
| +13% | +$44.2M | 2.55% | 17 |
|
|
2022
Q3 | $320M | Buy |
631,720
+4,350
| +0.7% | +$2.21M | 2.4% | 18 |
|
|
2022
Q2 | $341M | Sell |
627,370
-57,314
| -8% | -$31.1M | 2.44% | 17 |
|
|
2022
Q1 | $404M | Buy |
684,684
+63,200
| +10% | +$37.3M | 2.24% | 19 |
|
|
2021
Q4 | $415M | Buy |
621,484
+1,687
| +0.3% | +$1.13M | 2.12% | 21 |
|
|
2021
Q3 | $354M | Sell |
619,797
-7,468
| -1% | -$4.27M | 1.79% | 25 |
|
|
2021
Q2 | $316M | Buy |
627,265
+1,763
| +0.3% | +$889K | 1.66% | 28 |
|
|
2021
Q1 | $285M | Buy |
625,502
+14,254
| +2% | +$6.51M | 1.64% | 27 |
|
|
2020
Q4 | $285M | Sell |
611,248
-22,963
| -4% | -$10.7M | 1.85% | 26 |
|
|
2020
Q3 | $280M | Buy |
+634,211
| New | +$280M | 1.95% | 24 |
|